Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ADCC”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Early research (Phase 1)Study completedNCT00079716
What this trial is testing

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

Who this might be right for
Multiple Myeloma
Seagen Inc. 44
Testing effectiveness (Phase 2)UnknownNCT02315118
What this trial is testing

Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies

Who this might be right for
B-Cell Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
National University Hospital, Singapore 18
Testing effectiveness (Phase 2)Ended earlyNCT05099549
What this trial is testing

Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers

Who this might be right for
Squamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell LungColorectal Neoplasms+3 more
NKGen Biotech, Inc. 11
Early research (Phase 1)Study completedNCT04185220
What this trial is testing

Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome

Who this might be right for
Adult T-Cell Lymphoma/LeukemiaSezary SyndromeMycosis Fungoides
National Cancer Institute (NCI) 6
Early research (Phase 1)Looking for participantsNCT06630806
What this trial is testing

Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

Who this might be right for
Plasma Cell Myeloma Refractory
Sanofi 87
Testing effectiveness (Phase 2)Looking for participantsNCT06991114
What this trial is testing

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Who this might be right for
Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)Systemic Sclerosis (SSc)+6 more
Artiva Biotherapeutics, Inc. 90
Early research (Phase 1)Study completedNCT03816137
What this trial is testing

Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens

Who this might be right for
HIV-1-infection
Imperial College London 117
Large-scale testing (Phase 3)Study completedNCT03217422
What this trial is testing

ADCC Mediated B-Cell dEpletion and BAFF-R Blockade

Who this might be right for
Autoimmune Hepatitis
Novartis Pharmaceuticals 68
Early research (Phase 1)Study completedNCT03319459
What this trial is testing

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

Who this might be right for
HER2 Positive Gastric CancerColorectal CancerHead and Neck Squamous Cell Carcinoma+8 more
Fate Therapeutics 44
Early research (Phase 1)Ended earlyNCT03759184
What this trial is testing

Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia

Who this might be right for
LeukemiaLymphocyticChronic+1 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03571633
What this trial is testing

Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer

Who this might be right for
HER2-positive Breast CancerOperable Breast Cancer
Centre Leon Berard 90
Early research (Phase 1)Study completedNCT03663998
What this trial is testing

Optimising DNA Vaccinations in Healthy Volunteers

Who this might be right for
HIV-1-infection
Imperial College London 36
Large-scale testing (Phase 3)Ended earlyNCT00169104
What this trial is testing

Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function

Who this might be right for
Metastatic Breast Cancer
Dartmouth-Hitchcock Medical Center 23
Early research (Phase 1)Ended earlyNCT05930951
What this trial is testing

Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Who this might be right for
Adenoid Cystic Carcinoma of the Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 19
Early research (Phase 1)Study completedNCT00525447
What this trial is testing

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Seagen Inc. 36
Early research (Phase 1)Ended earlyNCT05462873
What this trial is testing

Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellEsophageal Squamous Cell Carcinoma+1 more
Novartis Pharmaceuticals 30
Not applicableStudy completedNCT05093192
What this trial is testing

Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia

Who this might be right for
Chronic Lymphocytic LeukemiaMinimal Residual Disease
University of Bath 26
Testing effectiveness (Phase 2)WithdrawnNCT03323424
What this trial is testing

Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers

Who this might be right for
Metastatic Breast CancerMetastatic Colorectal CancerMetastatic Head and Neck Cancer
Institut de Cancérologie de la Loire
Early research (Phase 1)UnknownNCT03554889
What this trial is testing

Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells

Who this might be right for
Advanced CancerADCCNK Cell Mediated Immunity+2 more
Hangzhou Cancer Hospital 21
Early research (Phase 1)Study completedNCT02689453
What this trial is testing

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

Who this might be right for
T-Cell Lymphoma RelapsedAdult T-Cell Leukemia (ATL)Peripheral T-Cell Lymphoma (PTCL)+2 more
National Cancer Institute (NCI) 11
Load More Results